Biopharmaceutical Analysis

Articles

The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.

Shimadzu and UMG Göttingen Enter Analytics Collaboration

The partnership between Waters and Sartorius aims to accelerate speed and increase accuracy in bioprocessing analysis.

Waters and Sartorius Enter Partnership to Improve Bioprocessing Analysis

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

Evolving Analytical Technology Unravels Protein Characteristics

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Almac Invests in Expanding Global Biologics Testing Solutions

Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.

Shimadzu’s New LCMS-8060NX Mass Spectrometer Offers Enhanced Performance

Analytical solutions are improving for raw material testing, process development, drug product release, and more.

Biopharma Analysis Benefits from New Technology and Methods

The following details some of the latest tools and systems available for biopharmaceutical laboratory operations.

The Latest in the Laboratory

Mario DiPaola is senior scientific director at Charles River Laboratories, Woburn, MA.

INDU JAVERI is president and CEO, CuriRx, Inc., Wilmington, MA.

Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.

Methods Accelerate Biosimilar Analysis

Real-time monitoring of product- and process-related impurities remains a challenge.

Analysis of Residual Impurities in Continuous Manufacturing

Valerie Theobald is director, immunoanalytical services at Charles River Laboratories. 

Jenifer Vija is scientific director, bioanalysis, at Charles River Laboratories.

Jessica St. Charles is director, laboratory sciences at Charles River Laboratories.

Christina Satterwhite, PhD, is senior director, global laboratory sciences at Charles River Laboratories. 

Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.

Biopharmaceutical Analysis: LC-MS